Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Author
CADTH Canadian Drug Expert Committee
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Showing
201
-
214
of
214
Search:
'CADTH Canadian Drug Expert Committee'
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
201
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...
Published 2018
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
202
CADTH Canadian drug expert committee recommendation: Siponimod (Mayzent -- Novartis Pharmaceuticals Canada Inc.) : indication : secondary progressive multiple sclerosis
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
203
CADTH Canadian drug expert committee recommendation: Cysteamine ophthalmic solution (Cystadrops -- recordati rare diseases Canada Inc.) : indication : treatment of corneal cystine...
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
204
CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
205
CADTH Canadian Drug Expert Committee final recommendation: Ticagrelor (Brilinta -- AstraZeneca Canada Inc.) indication : secondary prevention of atherothrombotic events
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
206
CADTH Canadian Drug Expert Committee final recommendation: Canagliflozin and metformin hydrochloride (Invokamet -- Janssen Inc.) : type 2 diabetes mellitus
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
207
CADTH Canadian Drug Expert Committee recommendation (final): Letermovir (Prevymis -- Merck Canada Inc.) indication : cytomegalovirus infection, prophylaxis
Published 2018
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
208
CADTH Canadian Drug Expert Committee final recommendation: Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) indication : type 2 diabetes
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
209
CADTH Canadian Drug Expert Committee recommendation: Dexamethasone (Ozurdex -- Allergan Canada Inc.) indication: for the treatment of adult patients with diabetic macular edema who...
Published 2018
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
210
CADTH Canadian Drug Expert Review Committee final recommendation: Riociguat (Adempas - Bayer HealthCare Inc.) : indication: pulmonary arterial hypertension
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
211
CADTH Canadian Drug Expert Committee recommendation: AbobotulinumtoxinA (Dysport therapeutic--Ipsen Biopharmaceuticals Canada, Inc.) : indication to reduce the subjective symptoms...
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
212
CADTH Canadian Drug Expert Committee final recommendation: Tesamorelin (Egrifta -- Theratechnologies Inc.) indication : HIV-associated lipohypertherapy
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
213
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (Orfadin -- Sobi Canada Inc.) : indication: the treatment of adult and pediatric patients with hereditary tyrosinemi...
Published 2018
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
214
CADTH Canadian Drug Expert Committee recommendation: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis C virus infection
Published 2018
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
1
2
3
4
5
6
7
8
9
10
11
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Author/Home?page=11&author=%22CADTH+Canadian+Drug+Expert+Committee%22&type=Author
Send by Email
×
Loading...